[
  {
    "pmid": 35922517,
    "title": "Single-cell transcriptomics reveals heterogeneity in tumor microenvironment",
    "abstract": "Understanding cellular heterogeneity in tumors is crucial for developing targeted therapies. Using single-cell RNA sequencing, we characterized 50,000 cells from primary tumors...",
    "authors": [
      {
        "last_name": "Smith",
        "fore_name": "John",
        "initials": "JA",
        "affiliation": "Department of Oncology, Harvard Medical School",
        "orcid": "0000-0001-2345-6789"
      },
      {
        "last_name": "Chen",
        "fore_name": "Wei",
        "initials": "W",
        "affiliation": "Broad Institute of MIT and Harvard"
      }
    ],
    "journal": {
      "title": "Nature",
      "iso_abbreviation": "Nature",
      "issn": "0028-0836",
      "volume": "608",
      "issue": "7923",
      "pub_date": {
        "year": 2022,
        "month": "Aug",
        "day": 18
      }
    },
    "pagination": "517-524",
    "doi": "10.1038/s41586-022-05087-2",
    "pmc_id": "PMC9876543",
    "publication_types": ["Journal Article", "Research Support, N.I.H., Extramural"],
    "mesh_terms": [
      {
        "descriptor_name": "Single-Cell Analysis",
        "descriptor_ui": "D059010",
        "major_topic": true,
        "qualifiers": [
          {
            "qualifier_name": "methods",
            "qualifier_ui": "Q000379"
          }
        ]
      },
      {
        "descriptor_name": "Tumor Microenvironment",
        "descriptor_ui": "D059016",
        "major_topic": true,
        "qualifiers": []
      }
    ],
    "keywords": ["single-cell RNA-seq", "tumor heterogeneity", "cancer immunology"],
    "grants": [
      {
        "grant_id": "R01 CA123456",
        "agency": "NCI NIH HHS",
        "country": "United States"
      }
    ],
    "metadata": {
      "date_created": "2022-08-04",
      "date_revised": "2023-01-15",
      "pub_status": "ppublish"
    }
  },
  {
    "pmid": 34876543,
    "title": "CRISPR-Cas9 genome editing: therapeutic applications and delivery challenges",
    "abstract": "CRISPR-Cas9 technology has revolutionized genome editing with potential therapeutic applications. This review summarizes current clinical trials and discusses delivery strategies...",
    "authors": [
      {
        "last_name": "Garcia",
        "fore_name": "Maria",
        "initials": "ML",
        "affiliation": "MIT Department of Biological Engineering"
      }
    ],
    "journal": {
      "title": "Nature Reviews Drug Discovery",
      "iso_abbreviation": "Nat Rev Drug Discov",
      "issn": "1474-1776",
      "volume": "21",
      "issue": "3",
      "pub_date": {
        "year": 2022,
        "month": "Mar"
      }
    },
    "pagination": "173-194",
    "doi": "10.1038/s41573-021-00374-9",
    "publication_types": ["Review", "Journal Article"],
    "mesh_terms": [
      {
        "descriptor_name": "CRISPR-Cas Systems",
        "descriptor_ui": "D064113",
        "major_topic": true,
        "qualifiers": []
      },
      {
        "descriptor_name": "Gene Editing",
        "descriptor_ui": "D000072669",
        "major_topic": true,
        "qualifiers": []
      }
    ],
    "keywords": ["CRISPR", "gene therapy", "genome editing", "clinical trials"],
    "metadata": {
      "date_created": "2021-12-10",
      "date_revised": "2022-06-20",
      "pub_status": "ppublish"
    }
  }
]
